Flexus Biosciences flexusbio.com


Public list: Smart Money VCs (6327) Pharma Startups (4729)

Flexus is a biotechnology company focused on the discovery, development, and commercialization of small-molecule cancer immunotherapies targeting regulatory T cells. The company is leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression (ARTIS). This disruptive approach to cancer therapy targets that which is common to all tumors, the host immune system.

Flexus is a biotechnology company focused on the discovery, development, and commercialization of small-molecule cancer immunotherapies targeting regulatory T cells. The company is leveraging unexploited insights in immunology to discover Agents for ...Show all

Company (Acquired)

Phone: 650-489-9000

Fax:

75 Shoreway Road
Suite D
San Carlos, 94070
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Flexus Biosciences $53.2M Feb 23, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Flexus Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Immunoregulatory agents Nov 05, 2015 May 09, 2017 Patent
Immunoregulatory agents Nov 05, 2015 Mar 21, 2017 Patent
Immunoregulatory agents Mar 27, 2017 Application
Immunoregulatory agents Feb 01, 2017 Application
Immunoregulatory agents Jun 05, 2015 Application